MICOM 2021

On 9th-11th July 2021, our Key Opinion Leader(s) (KOLs) from HUKM have joined the Malaysian International Virtual Conference on Menopause & Women's Health 2021 (MICOM 2021), that was held virtually due to the pandemic. We are very proud to share that our KOLs have successfully won the first prize for oral presentation with the presented study on primary dysmenorrhea, focusing in Obstetrics & Gynecology (O&G) department, titled: The Effect of Probiotics on Quality of Life in Women with Primary Dysmenorrhea: A Randomized, Double-Blind, Placebo-Controlled Trial. The intervention with probiotics on the patients was done for 3 months. This was announced through the link: http://www.medicineandhealthukm.com/article/malaysian-international-virtual-conference-menopause-women%E2%80%99s-health

Primary dysmenorrhea is commonly known as period pain that is usually faced by women on their menstruation phase. The study done showed that consuming HEXBIO may help in reducing the use of NSAIDS (painkillers) in women with the said issue. Our KOLs, who are also consultants from O&G department, usually prescribe patients with NSAIDS (to be taken when needed), together with HEXBIO as an adjunctive treatment. HEXBIO can be taken anytime regardless of their menstrual phase as it acts as a health supplement that can improve overall health and quality of life.